Advertisement
Home Tags Side Effects

Tag: Side Effects

The rate of muscle-related adverse event reports is increased when patients and their doctors are aware that statins are being used

Nocebo Effect Reported for Statin Therapy Use

0
Excess rate of muscle-related adverse event reports when patients are aware that statins being used
In a case report published online April 17 in the Journal of Clinical Pharmacy and Therapeutics

Case Report Describes Adverse Reaction to Clindamycin

0
Patient developed acute generalized exanthematous pustulosis after vancomycin, clindamycin use
In a case report published online Feb. 12 in the Journal of Clinical Pharmacy and Therapeutics

Drug-Induced Lupus Seen With Adalimumab Treatment

0
Patient with psoriasis developed muscle pain with paresthesia, ANA titer elevation with adalimumab
About half of early-stage breast cancer patients experience severe side effects from their treatment

Severe Side Effects Common Among Breast Cancer Patients

0
Forty-five percent of women studied said their side effects were severe or very severe
Anticholinergic medications are frequently prescribed to older adults

Burden of Anticholinergic Meds in Older Adults Must Be Considered

0
Often prescribed to older adults; measures developed for quantifying anticholinergic burden
Some high-risk women who take tamoxifen to prevent breast cancer may mistake naturally occurring nausea and vomiting for side effects of the drug and stop taking it

SABCS: Tamoxifen May Be Unfairly Blamed for Side Effects

0
Perceived side effects might lead some to stop taking the medication, researchers say
Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are associated with increased risk of gastrointestinal adverse events

GI Adverse Events Up With GLP-1 Receptor Agonists

0
Risk varies based on dose, background medications, and type of GLP-1 RA
Healthy participants receiving the orally administered reversible fatty acid amide hydrolase inhibitor

Severe Neurologic Disorder With Administration of BIA 10-2474

0
Phase 1 study involving healthy volunteers results in severe neurologic disorder, with one brain death
The multiple sclerosis drug alemtuzumab

Alemtuzumab May Reverse Some Disability in Newly-Diagnosed MS

0
Alemtuzumab modifies disability measures favorably compared with SC IFN-β-1a
Many randomized clinical trials involving spinal manipulative therapy do not report adverse events

Many Spinal Manipulation Trials Don’t Report Adverse Events

0
Significant increase in reporting of adverse events post-CONSORT statement of 2010